Arkolith/Insider Trading/ELYM/Form 4

Morisset Valerie

EVP, R&D AND CSOEliem Therapeutics, Inc. (ELYM) · full profile →Form 4 · filed Jul 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$357K
Net Open-Market Flow
-$357K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 16, 2024Sell(S)50K$7.13$357K202K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-019706) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML